Demonstrating rapid hemorrhage control and improved patient outcomes RIVERDALE, Md., April 7, 2021 /PRNewswire/ — Medcura, Inc., a commercial-stage medical device company, announced today that it has published the results of a peer-reviewed clinical study at the University of Chicago in this month’s Cardiovascular Catheterization and Interventions (CCI)https://www.medcurainc.com/publications/16998937.pdf. This first-in-human study evaluated the clinical use of […]
Other News
TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System
Panel votes 12 to 5 that benefits of OCS Heart System outweigh risks ANDOVER, Mass., April 6, 2021 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that after the review of TransMedics’ clinical […]
Enrollment Completed in Clinical Trial Evaluating Effect of Exclusive Human Milk Diet Including a Specialty Fortifier in Term Infants Born With Single Ventricle Physiology
DUARTE, Calif., April 7, 2021 /PRNewswire/ — Prolacta Bioscience, the world’s leading hospital provider of 100% human milk-based nutritional products, announced today that enrollment is now complete in a clinical trial evaluating the effect of an exclusive human milk diet (EHMD),1 including a specialty fortifier, for term infants who have undergone a corrective procedure for […]
Cardio Industry Executive Ed Rieflin Appointed to Chair Vvital Biomed
Ed Rieflin brings 19 years of leadership experience from Thoratec, St. Jude Medical and Abbott Laboratories to advance Vvital’s mitral valve solution MISGAV, Israel, April 7, 2021 /PRNewswire/ — Vvital Biomed Ltd. (“Vvital”), a portfolio company of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), announced the appointment of Ed Rieflin as Chair of the Board. Ed brings […]
NeuroVascular Quality Initiative-Quality Outcomes Database (NVQI-QOD) and the Society of Vascular and Interventional Neurology (SVIN) Form New Alliance
FAIRFAX, Va., April 7, 2021 /PRNewswire/ — The Society of NeuroInterventional Surgery (SNIS) and NeuroPoint Alliance (NPA) are pleased to welcome the Society of Vascular and Interventional Neurology (SVIN) to the NeuroVascular Quality Initiative-Quality Outcomes Database (NVQI-QOD). SVIN joins SNIS and NPA to expand the breadth and depth of the NVQI-QOD, the premier […]
Broward Health Medical Center Becomes First Hospital in Florida to Adopt Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders
ST. LOUIS, April 07, 2021 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that Broward Health Medical Center is establishing a robotic electrophysiology program to expand access to advanced minimally-invasive treatment of heart rhythm disorders in Florida. Broward Health Medical […]
Argon Medical Devices, Inc. Announces the Commercial Launch of the Halo™ Single-Loop Snare Kit
FRISCO, Texas, April 6, 2021 /PRNewswire/ — Argon Medical Devices, Inc. a leading manufacturer of medical devices focused exclusively on interventional procedures, announced the U.S. commercial launch of Halo™ Single-Loop Snare Kits. The Halo Single-Loop Snare Kit is designed to provide both accuracy and reliability when retrieving and manipulating foreign objects from the cardiovascular system […]
Abbott’s XIENCE™ Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk Patients
– New shorter duration of dual anti-platelet therapy (DAPT) post XIENCE stent implant provides physicians with additional options to treat patients at high risk of bleeding – XIENCE is the most used drug eluting stent in the world, and European approval for shorter DAPT is supported by two studies that […]
Cardiac Dimensions Welcomes Robert White to its Board of Directors
KIRKLAND, Wash., April 6, 2021 /PRNewswire/ — Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, today announced the election of Robert White as an independent director to its Board of Directors. Mr. White is a veteran medical technology executive, innovator […]
New Real-World Observational Analysis of UPTRAVI® (selexipag) Underscores the Importance of Risk Assessment for Treating Pulmonary Arterial Hypertension (PAH) Patients
Data from the SPHERE Registry published in the Journal of Heart and Lung Transplantation SOUTH SAN FRANCISCO, Calif., April 6, 2021 /PRNewswire/ — Findings from an analysis of the first 500 patients enrolled in the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry) found more than three-quarters (76%) of pulmonary arterial hypertension (PAH) patients […]



